Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000760644 | SCV000890536 | likely pathogenic | not provided | 2018-07-24 | criteria provided, single submitter | clinical testing | The R826X variant in the SZT2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R826X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret R826X as a likely pathogenic variant. |
Labcorp Genetics |
RCV000760644 | SCV004373006 | pathogenic | not provided | 2024-06-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg826*) in the SZT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SZT2 are known to be pathogenic (PMID: 23932106, 27248490, 28556953). This variant is present in population databases (rs767342365, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with SZT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 620280). For these reasons, this variant has been classified as Pathogenic. |